Seismic Therapeutic Announces Presentation of Preclinical Data for Immunoglobin Sculpting Enzyme and Dual-Cell Bidirectional Antibody Programs at IMMUNOLOGY 2023 - Yahoo Finance
TLPFY Stock | USD 45.60 1.28 2.89% |
Slightly above 55% of Teleperformance's investors are presently thinking to get in. The analysis of overall sentiment of trading Teleperformance PK pink sheet suggests that some investors are interested at this time. Teleperformance's investing sentiment can be driven by a variety of factors including economic data, Teleperformance's earnings reports, geopolitical events, and overall market trends.
Teleperformance |
Seismic Therapeutic Announces Presentation of Preclinical Data for Immunoglobin Sculpting Enzyme and Dual-Cell Bidirectional Antibody Programs at IMMUNOLOGY 2023 Yahoo Finance
Read at news.google.com
Teleperformance Fundamental Analysis
We analyze Teleperformance's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teleperformance using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teleperformance based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Teleperformance is currently under evaluation in five year return category among its peers. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Teleperformance PK Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teleperformance pink sheet to make a market-neutral strategy. Peer analysis of Teleperformance could also be used in its relative valuation, which is a method of valuing Teleperformance by comparing valuation metrics with similar companies.
Peers
Teleperformance Related Equities
TLPFF | Teleperformance | 3.34 | ||||
IKTSY | Intertek Group | 2.40 | ||||
MITFY | Mitie Group | 0.18 | ||||
HZNOF | Dexterra | 2.07 | ||||
DCMDF | DATA Communications | 3.80 |
Additional Tools for Teleperformance Pink Sheet Analysis
When running Teleperformance's price analysis, check to measure Teleperformance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teleperformance is operating at the current time. Most of Teleperformance's value examination focuses on studying past and present price action to predict the probability of Teleperformance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teleperformance's price. Additionally, you may evaluate how the addition of Teleperformance to your portfolios can decrease your overall portfolio volatility.